Kara E Walter, MD | |
1223 16th St Ste 3100, Santa Monica, CA 90404-1275 | |
(310) 582-6240 | |
(424) 259-7789 |
Full Name | Kara E Walter |
---|---|
Gender | Female |
Speciality | Gastroenterology |
Experience | 12 Years |
Location | 1223 16th St Ste 3100, Santa Monica, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467727776 | NPI | - | NPPES |
1467727776 | Medicaid | WA |
Facility Name | Location | Facility Type |
---|---|---|
Kaiser Sunnyside Medical Center | Clackamas, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
Criticism about Health and Human Services Sec. Kathleen Sebelius' appearance at the Jesuit institution has mounted this week because of her role in the Obama administration's rule on contraception requirements in the health care law.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction - achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).
Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system.
› Verified 3 days ago
Entity Name | Kaiser Foundation Health Plan Of The Northwest |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
Criticism about Health and Human Services Sec. Kathleen Sebelius' appearance at the Jesuit institution has mounted this week because of her role in the Obama administration's rule on contraception requirements in the health care law.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction - achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).
Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kara E Walter, MD 5767 W Century Blvd Ste 400, Los Angeles, CA 90045-5631 Ph: () - | Kara E Walter, MD 1223 16th St Ste 3100, Santa Monica, CA 90404-1275 Ph: (310) 582-6240 |
News Archive
Criticism about Health and Human Services Sec. Kathleen Sebelius' appearance at the Jesuit institution has mounted this week because of her role in the Obama administration's rule on contraception requirements in the health care law.
Enzon Pharmaceuticals, Inc. today announced the publication of preclinical data demonstrating that PEG-SN38 (EZN-2208), the Company's novel PEGylated DNA topoisomerase I inhibitor, led to significantly greater tumor regression as compared to CPT-11 (irinotecan) in both in vitro and in vivo models of pediatric neuroblastoma.
Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction - achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).
Researchers at the University of Georgia report in the Journal of Biological Chemistry that an enzyme known as Tumor Progression Locus 2, or Tpl2, plays a key role in directing and regulating several important components of the body's immune system.
› Verified 3 days ago
Irawan Susanto, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1223 16th St, Suite 3400, Santa Monica, CA 90404 Phone: 310-449-0939 Fax: 424-259-7790 | |
Louis Ravitz, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2336 Santa Monica Blvd, Suite 207, Santa Monica, CA 90404 Phone: 310-828-9311 Fax: 310-453-8533 | |
Janet Winikoff, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2001 Santa Monica Blvd Ste 860, Santa Monica, CA 90404 Phone: 310-828-3209 Fax: 310-828-5165 | |
Dr. Sean Dooley, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2121 Santa Monica Blvd, Santa Monica, CA 90404 Phone: 323-829-8745 | |
Lorraine Anderson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1245 16th St Ste 303, Santa Monica, CA 90404 Phone: 310-481-4646 Fax: 310-899-7599 | |
Dr. Colleen Lucy Channick, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1223 16th St Ste 3400, Santa Monica, CA 90404 Phone: 310-449-0939 | |
Carol Yukiko Nishikubo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2001 Santa Monica Blvd Ste 560w, Santa Monica, CA 90404 Phone: 310-453-5654 Fax: 310-453-6885 |